Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-24-042120

Director acquired 892 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2024-09-03 Other acquisition 10b5-1 +50 $1.38 $69 35,603 D
Jones James Director 2024-09-04 Other acquisition 10b5-1 +47 $1.35 $63 35,650 D
Jones James Director 2024-09-05 Other acquisition 10b5-1 +46 $1.28 $59 35,696 D
Jones James Director 2024-09-06 Other acquisition 10b5-1 +10 $1.30 $13 35,706 D
Jones James Director 2024-09-09 Other acquisition 10b5-1 +50 $1.33 $67 35,756 D
Jones James Director 2024-09-10 Other acquisition 10b5-1 +31 $1.30 $40 35,787 D
Jones James Director 2024-09-11 Other acquisition 10b5-1 +48 $1.35 $65 35,835 D
Jones James Director 2024-09-12 Other acquisition 10b5-1 +50 $1.35 $68 35,885 D
Jones James Director 2024-09-13 Other acquisition 10b5-1 +50 $1.30 $65 35,935 D
Jones James Director 2024-09-16 Other acquisition 10b5-1 +50 $1.30 $65 35,985 D
Jones James Director 2024-09-17 Other acquisition 10b5-1 +50 $1.30 $65 36,035 D
Jones James Director 2024-09-18 Other acquisition 10b5-1 +50 $1.30 $65 36,085 D
Jones James Director 2024-09-19 Other acquisition 10b5-1 +50 $1.29 $65 36,135 D
Jones James Director 2024-09-20 Other acquisition 10b5-1 +50 $1.30 $65 36,185 D
Jones James Director 2024-09-23 Other acquisition 10b5-1 +50 $1.25 $63 36,235 D
Jones James Director 2024-09-24 Other acquisition 10b5-1 +15 $1.22 $18 36,250 D
Jones James Director 2024-09-25 Other acquisition 10b5-1 +39 $1.29 $50 36,289 D
Jones James Director 2024-09-26 Other acquisition 10b5-1 +50 $1.24 $62 36,339 D
Jones James Director 2024-09-27 Other acquisition 10b5-1 +44 $1.24 $55 36,383 D
Jones James Director 2024-09-30 Other acquisition 10b5-1 +62 $1.36 $84 36,445 D
Loading xslF345X05/wk-form4_1727986080.xml…